0001193125-18-038103.txt : 20180209 0001193125-18-038103.hdr.sgml : 20180209 20180209164603 ACCESSION NUMBER: 0001193125-18-038103 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20180209 DATE AS OF CHANGE: 20180209 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Pulse Biosciences, Inc. CENTRAL INDEX KEY: 0001625101 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 465696597 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-89516 FILM NUMBER: 18592415 BUSINESS ADDRESS: STREET 1: 3957 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 510-906-4600 MAIL ADDRESS: STREET 1: 3957 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 FORMER COMPANY: FORMER CONFORMED NAME: Electroblate, Inc. DATE OF NAME CHANGE: 20141113 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: NewBEM Corp. CENTRAL INDEX KEY: 0001674475 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 849 MITTEN ROAD, SUITE 104 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 650-697-3939 MAIL ADDRESS: STREET 1: 849 MITTEN ROAD, SUITE 104 CITY: BURLINGAME STATE: CA ZIP: 94010 SC 13G 1 d532143dsc13g.htm SC 13G SC 13G

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13G

Under the Securities Exchange Act of 1934

(Amendment No. N/A )*

 

 

Pulse Biosciences, Inc.

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

74587B 10 1

(CUSIP Number)

December 31, 2016

(Date of Event which Requires Filing of this Statement)

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

Rule 13d-1(b)

 

Rule 13d-1(c)

 

Rule 13d-1(d)

 

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 


CUSIP No. 74587B 10 1  

 

  1.   

Names of Reporting Persons.

 

NewBEM Corporation

  2.  

Check the Appropriate Box if a Member of a Group (See Instructions)

(a)  ☐        (b)  ☐

 

  3.  

SEC Use Only

 

  4.  

Citizenship or Place of Organization

 

United States

Number of 

Shares 

Beneficially 

Owned by 

Each 

Reporting 

Person  With: 

   5.    

Sole Voting Power

 

975,159 (1)

   6.   

Shared Voting Power

 

0

   7.   

Sole Dispositive Power

 

975,159 (1)

   8.   

Shared Dispositive Power

 

0

  9.   

Aggregate Amount Beneficially Owned by Each Reporting Person

 

975,159 (1)

10.  

Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)

 

11.  

Percent of Class Represented by Amount in Row (9)

 

7.3% (2)

12.  

Type of Reporting Person (See Instructions)

 

CO

 

(1) Represents (i) 969,048 shares of Common Stock directly held by the Reporting Person and (ii) options to purchase 5,861 shares and 250 shares of Common Stock granted to employees Richard Nuccitelli, Ph.D and Pamela Nuccitelli respectively that are exercisable within 60 days of December 31, 2016. Each of Richard Nuccitelli, Ph.D and Pamela Nuccitelli may be deemed to share voting and dispositive power over the shares of Common Stock held by NewBEM Corporation.
(2) Based on 13,315,297 of the Issuer’s Common Stock outstanding as of December 31, 2016 and assumes that 6,111 shares underlying the Common Stock options exercisable within 60 days of December 31, 2016 are deemed outstanding pursuant to SEC Rule 13d-3(d)(1)(i).

 

Page 2 of 5


Item 1(a) Name of Issuer: Pulse Biosciences, Inc.

 

Item 1(b) Address of Issuer’s Principal Executive Offices: 3957 Point Eden Way, Hayward, CA 94545

 

Item 2(a) Name of Person Filing: NewBEM Corporation

 

Item 2(b) Address of Principal Business Office or, if none, Residence: 1270 Manzanita Drive, Millbrae, CA 94030

 

Item 2(c) Citizenship: United States

 

Item 2(d) Title of Class of Securities: Common Stock, par value $0.001 per share

 

Item 2(e) CUSIP Number: 74587B 10 1

 

Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:

Not applicable.

 

Item 4. Ownership

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

  (a) Amount beneficially owned: 975,159 shares

 

  (b) Percent of class: 7.3%.

 

  (c) Number of shares as to which the person has:

 

  (i) Sole power to vote or to direct the vote: 975,159 shares

 

  (ii) Shared power to vote or to direct the vote: 0 shares

 

  (iii) Sole power to dispose or to direct the disposition of: 975,159 shares

 

  (iv) Shared power to dispose or to direct the disposition of: 0 shares

 

Item 5. Ownership of Five Percent or Less of a Class

Not applicable.

 

Item 6. Ownership of More than Five Percent on Behalf of Another Person

Not applicable.

 

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person

Not applicable.

 

Item 8. Identification and Classification of Members of the Group

Not applicable.

 

Page 3 of 5


Item 9. Notice of Dissolution of Group

Not applicable.

 

Item 10. Certification

Not applicable.

 

Page 4 of 5


SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 9, 2018

 

NEWBEM CORPORATION
By:  

/s/ Richard Nuccitelli

Name: Richard Nuccitelli
Title: Vice President

 

Page 5 of 5